FTC monitoring how drug companies react to patent cliff, official says.
Share this article
Regulation
Score 65
Neutral
FTC monitoring how drug companies react to patent cliff, official says
Mar 17, 2026 22:09 UTC
XLV, PFE, JNJ
Medium term
Related Articles
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.